HempNewsBreaks – Earth Science Tech, Inc. (ETST) Provides Update on CBD Formula Patents, Medical Device Progress

Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, this morning provided an update regarding its ongoing CBD formula patents and medical device progress. Per the update, the prototyping of three CBD formula patents, which the company received a grant from the Government of Quebec to develop, has begun. The initial batch will be tested by the team and in vitro testing is expected to begin in summer 2019 to demonstrate the superior antioxidant activities and improved anti-proliferative effects on breast cancer cells. The third product is a superfood edible that is anticipated to be ready for Q4 of 2018. In addition, the company reported that it is currently working with Accélération, Design et Innovation Inc. regarding the final packaging of its MSN-2 medical device in preparation of its upcoming launch. “The official launch of this medical device is a little like giving birth. It will be unique in the marketplace and we are branding this device globally. The commercial name will be announced soon, as we are in the process of trademark protection for the logo and name. We will create a strong demand for this medical device by showing the world its powerful capacity to diminish the prevalence of chlamydia and other Sexually Transmitted Infections,” Earth Science Tech CEO and Chief Science Officer Dr. Michel Aubé stated in the news release.

To view the full press release, visit http://cnw.fm/S1Os5

About Earth Science Tech, Inc.

Earth Science Tech, Inc. offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, and studies through DV Biologics prove it lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market. For more information, visit the company’s website at www.EarthScienceTech.com.

More from CannabisNewsBreaks

• HempNewsBreaks – Golden Triangle Ventures Inc. (OTC: GTVH) Restructures $7 Million in Legacy Debt, Secures Repurchase Option
• HempNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model
• HempNewsBreaks – CannabisNewsWire Named Official Newswire of 2025 Cannabis Means Business Expo in NYC 

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net